When biotech investor Flagship Pioneering announced that it had hired former Food and Drug Administration Commissioner Stephen Hahn, more than a few eyebrows rose.
“It would not be a good look for our industry if the person who approved the vaccine went to work for an affiliated company,” tweeted Brad Loncar, a respected investor. “That would be a TERRIBLE look for both him and Flagship,” one biotech editor tweeted.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
